[IF=21.7]Engineered Pericyte-Targeted Extracellular Vesicles Protect Against Hypoperfusion-Induced Cognitive Impairment and Vascular Demyelination-First published: 01 June 2026
发布日期：2026/8/25 9:48:21
作者：Weiwei Shen, Weishi Liu, Min Guo, Tongyao You, Yingzhe Wang, Tiansiyu Wen, Suzhen Liang, Xiaodi Xie, Yanfeng Jiang, Qiang Dong, Jin-Tai Yu, Mei Cui
科研单位：Department of Neurology and National Centerfor Neurological Disorders, Huashan Hospital,Fudan University, Shanghai, China
期刊:Journal of Extracellular Vesicles
DOI：10.1002/jev2.70319
影响因子:21.7
引用产品:[FS0994] Exosome-Free FBS 去外泌体血清
科研单位：Department of Neurology and National Centerfor Neurological Disorders, Huashan Hospital,Fudan University, Shanghai, China
期刊:Journal of Extracellular Vesicles
DOI：10.1002/jev2.70319
影响因子:21.7
引用产品:[FS0994] Exosome-Free FBS 去外泌体血清
上一篇：[IF=6.5]Programmed Synergistic Photochemotherapy and Immune Activation of Triple Negative Breast Cancer Using Anti-PD-L1 Antibody-Conjugated Multifunctional Nanocapsules-International Journal of Nanomedicine Published: 8 January 2026
下一篇：[IF=5.6]Loss of TIMM8A Inhibits Breast Cancer Progression Through Promoting HSPA9 Ubiquitination and Degradation via Competitive Interaction with RNF4-Published: 18 August 2026
下一篇：[IF=5.6]Loss of TIMM8A Inhibits Breast Cancer Progression Through Promoting HSPA9 Ubiquitination and Degradation via Competitive Interaction with RNF4-Published: 18 August 2026
.jpg)
